Literature DB >> 27797380

DNA demethylation induces SALL4 gene re-expression in subgroups of hepatocellular carcinoma associated with Hepatitis B or C virus infection.

H Fan1,2, Z Cui1,2, H Zhang1,2, S K Mani1,2, A Diab1,2, L Lefrancois3, N Fares3, P Merle3, O Andrisani1,2.   

Abstract

Sal-like protein 4 (SALL4), an embryonic stem cell transcriptional regulator, is re-expressed by an unknown mechanism in poor prognosis hepatocellular carcinoma (HCC), often associated with chronic hepatitis B virus (HBV) infection. Herein, we investigated the mechanism of SALL4 re-expression in HBV-related HCCs. We performed bisulfite sequencing PCR of genomic DNA isolated from HBV-related HCCs and HBV replicating cells, and examined DNA methylation of a CpG island located downstream from SALL4 transcriptional start site (TSS). HBV-related HCCs expressing increased SALL4 exhibited demethylation of specific CpG sites downstream of SALL4 TSS. Similarly, SALL4 re-expression and demethylation of these CpGs was observed in HBV replicating cells. SALL4 is also re-expressed in poor prognosis HCCs of other etiologies. Indeed, increased SALL4 expression in hepatitis C virus-related HCCs correlated with demethylation of these CpG sites. To understand how CpG demethylation downstream of SALL4 TSS regulates SALL4 transcription, we quantified by chromatin immunoprecipitation (ChIP) assays RNA polymerase II occupancy of SALL4 gene, as a function of HBV replication. In absence of HBV replication, RNA polymerase II associated with SALL4 exon1. By contrast, in HBV replicating cells RNA polymerase II occupancy of all SALL4 exons increased, suggesting CpG demethylation downstream from SALL4 TSS influences SALL4 transcriptional elongation. Intriguingly, demethylated CpGs downstream from SALL4 TSS are within binding sites of octamer-binding transcription factor 4 (OCT4) and signal transducer and activator of transcription3 (STAT3). ChIP assays confirmed occupancy of these sites by OCT4 and STAT3 in HBV replicating cells, and sequential ChIP assays demonstrated co-occupancy with chromatin remodeling BRG1/Brahma-associated factors. BRG1 knockdown reduced SALL4 expression, whereas BRG1 overexpression increased SALL4 transcription in HBV replicating cells. We conclude demethylation of CpGs located within OCT4 and STAT3 cis-acting elements, downstream of SALL4 TSS, enables OCT4 and STAT3 binding, recruitment of BRG1, and enhanced RNA polymerase II elongation and SALL4 transcription.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27797380      PMCID: PMC5408304          DOI: 10.1038/onc.2016.399

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  40 in total

1.  Core transcriptional regulatory circuitry in human embryonic stem cells.

Authors:  Laurie A Boyer; Tong Ihn Lee; Megan F Cole; Sarah E Johnstone; Stuart S Levine; Jacob P Zucker; Matthew G Guenther; Roshan M Kumar; Heather L Murray; Richard G Jenner; David K Gifford; Douglas A Melton; Rudolf Jaenisch; Richard A Young
Journal:  Cell       Date:  2005-09-23       Impact factor: 41.582

2.  MethPrimer: designing primers for methylation PCRs.

Authors:  Long-Cheng Li; Rajvir Dahiya
Journal:  Bioinformatics       Date:  2002-11       Impact factor: 6.937

3.  SWI/SNF-Brg1 regulates self-renewal and occupies core pluripotency-related genes in embryonic stem cells.

Authors:  Benjamin L Kidder; Stephen Palmer; Jason G Knott
Journal:  Stem Cells       Date:  2009-02       Impact factor: 6.277

4.  Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.

Authors:  Fei Yin; Xin Han; Shu-Kun Yao; Xiao-Ling Wang; Hui-Chai Yang
Journal:  World J Gastroenterol       Date:  2016-03-07       Impact factor: 5.742

5.  Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.

Authors:  J G Herman; J R Graff; S Myöhänen; B D Nelkin; S B Baylin
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

6.  The developmental potential of iPSCs is greatly influenced by reprogramming factor selection.

Authors:  Yosef Buganim; Styliani Markoulaki; Niek van Wietmarschen; Heather Hoke; Tao Wu; Kibibi Ganz; Batool Akhtar-Zaidi; Yupeng He; Brian J Abraham; David Porubsky; Elisabeth Kulenkampff; Dina A Faddah; Linyu Shi; Qing Gao; Sovan Sarkar; Malkiel Cohen; Johanna Goldmann; Joseph R Nery; Matthew D Schultz; Joseph R Ecker; Andrew Xiao; Richard A Young; Peter M Lansdorp; Rudolf Jaenisch
Journal:  Cell Stem Cell       Date:  2014-09-04       Impact factor: 24.633

7.  The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming.

Authors:  Abed AlFatah Mansour; Ohad Gafni; Leehee Weinberger; Asaf Zviran; Muneef Ayyash; Yoach Rais; Vladislav Krupalnik; Mirie Zerbib; Daniela Amann-Zalcenstein; Itay Maza; Shay Geula; Sergey Viukov; Liad Holtzman; Ariel Pribluda; Eli Canaani; Shirley Horn-Saban; Ido Amit; Noa Novershtern; Jacob H Hanna
Journal:  Nature       Date:  2012-08-16       Impact factor: 49.962

8.  SALL4 Expression in Hepatocellular Carcinomas Is Associated with EpCAM-Positivity and a Poor Prognosis.

Authors:  Hyunjin Park; Hyejung Lee; An Na Seo; Jai Young Cho; Young Rok Choi; Yoo-Seok Yoon; Ho-Seong Han; Young Nyun Park; Haeryoung Kim
Journal:  J Pathol Transl Med       Date:  2015-08-10

9.  Rate of elongation by RNA polymerase II is associated with specific gene features and epigenetic modifications.

Authors:  Artur Veloso; Killeen S Kirkconnell; Brian Magnuson; Benjamin Biewen; Michelle T Paulsen; Thomas E Wilson; Mats Ljungman
Journal:  Genome Res       Date:  2014-04-08       Impact factor: 9.043

10.  Hepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2.

Authors:  H Fan; H Zhang; P E Pascuzzi; O Andrisani
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

View more
  12 in total

Review 1.  Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer.

Authors:  Sayyed K Zaidi; Seth E Frietze; Jonathan A Gordon; Jessica L Heath; Terri Messier; Deli Hong; Joseph R Boyd; Mingu Kang; Anthony N Imbalzano; Jane B Lian; Janet L Stein; Gary S Stein
Journal:  Mol Cell Biol       Date:  2017-11-13       Impact factor: 4.272

2.  SALL4 oncogene is an immunogenic antigen presented in various HLA-DR contexts.

Authors:  Marie Kroemer; Laurie Spehner; Patricia Mercier-Letondal; Laura Boullerot; Stefano Kim; Marine Jary; Jeanne Galaine; Emilie Picard; Christophe Ferrand; Thierry Nguyen; Fabrice Larosa; Olivier Adotévi; Yann Godet; Christophe Borg
Journal:  Oncoimmunology       Date:  2018-01-17       Impact factor: 8.110

Review 3.  Cancer stem cells in hepatocellular carcinoma - from origin to clinical implications.

Authors:  Terence Kin-Wah Lee; Xin-Yuan Guan; Stephanie Ma
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2021-09-09       Impact factor: 46.802

4.  Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer.

Authors:  Kiyoshi Misawa; Daiki Mochizuki; Atsushi Imai; Yuki Misawa; Shiori Endo; Masato Mima; Hideya Kawasaki; Thomas E Carey; Takeharu Kanazawa
Journal:  Clin Epigenetics       Date:  2017-06-12       Impact factor: 6.551

5.  Molecular Mechanism for Protection Against Liver Failure in Human Yellow Fever Infection.

Authors:  Fernanda de Oliveira Lemos; Andressa França; Antônio Carlos Melo Lima Filho; Rodrigo M Florentino; Marcone Loiola Santos; Dabny G Missiaggia; Gisele Olinto Libanio Rodrigues; Felipe Ferraz Dias; Ingredy Beatriz Souza Passos; Mauro M Teixeira; Antônio Márcio de Faria Andrade; Cristiano Xavier Lima; Paula Vieira Teixeira Vidigal; Vivian Vasconcelos Costa; Matheus Castro Fonseca; Michael H Nathanson; M Fatima Leite
Journal:  Hepatol Commun       Date:  2020-03-16

6.  Association between gene methylation and HBV infection in hepatocellular carcinoma: A meta-analysis.

Authors:  Cheng Zhang; Changxin Huang; Xinbing Sui; Xueqing Zhong; Wenjun Yang; Xiangrong Hu; Yongqiang Li
Journal:  J Cancer       Date:  2019-10-20       Impact factor: 4.207

7.  Lipoprotein-Like Nanoparticle Carrying Small Interfering RNA Against Spalt-Like Transcription Factor 4 Effectively Targets Hepatocellular Carcinoma Cells and Decreases Tumor Burden.

Authors:  William Cruz; Huang Huang; Brian Barber; Elisa Pasini; Lili Ding; Gang Zheng; Juan Chen; Mamatha Bhat
Journal:  Hepatol Commun       Date:  2020-03-16

8.  Epigenetic Modulation of TLR4 Expression by Sulforaphane Increases Anti-Inflammatory Capacity in Porcine Monocyte-Derived Dendritic Cells.

Authors:  Xueqi Qu; Christiane Neuhoff; Mehmet Ulas Cinar; Maren Pröll; Ernst Tholen; Dawit Tesfaye; Michael Hölker; Karl Schellander; Muhammad Jasim Uddin
Journal:  Biology (Basel)       Date:  2021-05-31

9.  Epigenetic modification of SALL1 as a novel biomarker for the prognosis of early stage head and neck cancer.

Authors:  Kiyoshi Misawa; Yuki Misawa; Atsushi Imai; Daiki Mochizuki; Shiori Endo; Masato Mima; Ryuji Ishikawa; Hideya Kawasaki; Takashi Yamatodani; Takeharu Kanazawa
Journal:  J Cancer       Date:  2018-02-28       Impact factor: 4.207

Review 10.  SALL Proteins; Common and Antagonistic Roles in Cancer.

Authors:  Claudia Álvarez; Aracelly Quiroz; Diego Benítez-Riquelme; Elizabeth Riffo; Ariel F Castro; Roxana Pincheira
Journal:  Cancers (Basel)       Date:  2021-12-15       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.